Antoine Andremont

UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.

BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon.

Famar Health Care Services is a Greek European company that specializes in pharmaceutical manufacturing and development services. The company is based in Athens, Greece. With a legacy of 70 years of technology expertise, Famar is a leading provider in the industry. and has subsidiaries in Spain. Kostas Rengis has been the CEO of the company since 2021.

eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France.

JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.

Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes.

UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain

Part of UCB SA, Vedim Pharma SA is a French pharmaceutical company that manufactures pharmaceuticals.

GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France.

Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné.

eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation.